Are these calls for papers currently accepting submissions?

Records are included only when the publisher source exposes a deadline on or after the database date. Authors should still verify the publisher page before submitting.

Do the pages replace journal submission guidelines?

No. The pages help researchers discover CFPs and generate research ideas, but submission rules, scope, fees, and reference style must be checked on the official publisher page.

DrAIStudio

Diabetes, Metabolic Syndrome and Obesity call for papers

Current call-for-papers opportunities for Diabetes, Metabolic Syndrome and Obesity. Ranking signals: Indexed (Active), JIF 3.0. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for Diabetes, Metabolic Syndrome and Obesity

Behavioral and Psychosocial Aspects in the Management and Treatment of Diabetes and Obesity

Deadline 2026-09-30Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

Diabetes and obesity remain major challenges for modern societies, not only because of their rising prevalence but also due to the substantial burden they place on people living with these conditions and their families. Although medical care has advanced significantly—with new medications, improved insulin formulations, and modern technologies—clinical outcomes often remain suboptimal. Increasing evidence highlights…

Generate research ideas Open CFP source Submit

Real World Evidence for the Pharmacological Treatment of Diabetes: From Clinical Trials to Routine Practice

Deadline 2026-12-31Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

Diabetes mellitus represents one of the most pressing global health challenges of the 21st century, affecting over 500 million adults worldwide. The pharmacological landscape for diabetes has expanded rapidly, with the introduction of incretin-based therapies, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and dual-acting agents alongside established glucose-lowering drug classes. While randomized controlled tri…

Generate research ideas Open CFP source Submit

Environmental Determinants of Obesity and Diabetes: Endocrine Disruptors, Pollutants, and Metabolic Risk

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

The global rise in obesity and diabetes has traditionally been attributed to lifestyle factors such as diet and physical inactivity; however, accumulating evidence highlights the critical contribution of environmental determinants to metabolic disease. Among these, endocrine-disrupting chemicals (EDCs) and environmental pollutants have emerged as key drivers of metabolic dysregulation. Widely present in air, water,…

Generate research ideas Open CFP source Submit

Global Trends in Type 1 and Severe Insulin Sufficient Diabetes: Incidence, Diagnosis and Management

Deadline 2027-02-28Taylor & FrancisIndexed (Active)

Journal: Diabetes, Metabolic Syndrome and Obesity

Recent years have seen a change in the diagnostic classification scheme for type 1 diabetes, such that persons with severe insulin deficiency and presentation with diabetic ketoacidosis at diagnosis, but in the absence of classic type 1 diabetes autoantibodies, are now classified as having type 2 diabetes rather than type 1 diabetes. How this may influence the treatment, or change the treatment, of persons with diab…

Generate research ideas Open CFP source Submit

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.